About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Detroit | 7,240 Studies Near You

Clinical TrialsDetroit

Clinical Trials in Detroit

Discover 7,240 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2741-2760 of 7,240 trials

TerminatedProject 1: ACHIEVE- HTNThis project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health Inequities by Early PreVEntion in the GREAT LakEs Region) Center (IRB 100221MP2A), the purpose of…NCT05295758·Detroit, Michigan CompletedCOVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) TrialThe purpose of this study is to evaluate the safety, dose-requirements, and exploratory efficacy of twice-daily subcutaneous enoxaparin as venous thromboembolism prophylaxis in…NCT04354155·Birmingham, Alabama and 15 others

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

TerminatedDasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin LymphomaThis study uses a drug called dasatinib to produce an anti-cancer effect called large granular lymphocyte cellular expansion.NCT01609816·Detroit, Michigan

RecruitingStudy to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsGlobal, Phase 3, randomized, multicenter, open-label study evaluating the efficacy and safety of firmonertinib at a dose level of 240 mg QD compared to investigator's choice of…NCT07185997·Fullerton, California and 117 others

RecruitingSTOP-HAE: A Phase 3 Study of ADX-324 in HAEThis study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema.NCT06960213·Litchfield Park, Arizona and 69 others

CompletedTislelizumab in Participants With Relapsed or Refractory Classical Hodgkin LymphomaThis was a Phase 2 trial evaluating the effectiveness and safety of tislelizumab in participants with relapsed or hard-to-treat classical Hodgkin lymphoma (cHL).NCT04318080·Detroit, Michigan and 3 others

CompletedChemotherapy in Treating Patients With Advanced Kidney CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00011973·Detroit, Michigan and 3 others

TerminatedStudy Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast CancerThis is a research study in 2 parts assessing the following parameters of the combination of the study drug called bosutinib, and a drug called capecitabine: the safety, how well…NCT00959946·Boston, Massachusetts and 6 others

CompletedMedtronic CoreValve Evolut R U.S. Clinical StudyThe study objectives are to assess the safety and efficacy of the CoreValve Evolut R transcatheter aortic valve replacement (TAVR) system in patients with severe symptomatic…NCT02207569·Phoenix, Arizona and 22 others

CompletedComparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic LeukemiaThis open-label, multicenter, randomized Phase III study is designed to compare the efficacy and safety of a combined regimen of obinutuzumab and venetoclax versus obinutuzumab +…NCT02242942·Gilbert, Arizona and 121 others

CompletedRuxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis phase I/II trial studies the side effects and the best dose of ruxolitinib phosphate when given together with paclitaxel and carboplatin and to see how well they work in…NCT02713386·Goodyear, Arizona and 109 others

RecruitingComparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated BiomarkersThe purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers.NCT04239573·Birmingham, Alabama and 428 others

CompletedEfficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine FibroidsThe primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy…NCT03070951·Chino, California and 95 others

TerminatedStudy of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)Determining the efficacy, based upon overall survival, of ruxolitinib added to capecitabine for the treatment of advanced or metastatic pancreatic cancer.NCT02117479·Avondale, Arizona and 229 others

CompletedAn In Vivo Model for Postinflammatory HyperpigmentationPost-inflammatory hyperpigmentation (PIH) is an acquired hypermelanosis that occurs after cutaneous inflammation or injury that frequently affects darker skinned populations.NCT02905903·Detroit, Michigan

CompletedCarboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After DocetaxelRATIONALE: Drugs used in chemotherapy, such as carboplatin and prednisone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…NCT01051570·Evanston, Illinois and 3 others

CompletedIMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific AntibodyThis study is being done to evaluate how long the immune response from the Human Papilloma Virus (HPV) vaccine you / your child received persists.NCT01206556·Long Beach, California and 22 others

RecruitingTo Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLPart 1: This is a 5 Arm study primarily to determine the best dose out of the two dose levels of Belinostat and Pralatrexate combined with CHOP/COP in newly diagnosed PTCL…NCT06072131·Clovis, California and 68 others

CompletedExercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)This is a Phase III, randomized, unblinded, multicenter, prospective comparative study.NCT01278927·Duarte, California and 18 others

CompletedStudy of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk ChildrenThe primary objective of this study was to compare the safety and efficacy of motavizumab to palivizumab when administered monthly by intramuscular (IM) injection for the…NCT00129766·Birmingham, Alabama and 343 others

PreviousPage 138 of 362Next

in Detroit

Heart Diseasein Detroit